This Project Grant award of $1,120,455 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support a secondary data analysis study to examine the impact of employment insecurity on substance use among U.S. adults. The study aims to elucidate the time course of effects, identify moderating systemic environmental and individual factors, and explore the underlying mechanisms linking employment insecurity to substance use. The...
This federal Project Grant award, totaling $3,580,802.00, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The goal of the project is to investigate the mechanisms governing stress-immune interactions in people living with HIV (PLWH), and how major depressive disorder (MDD) and cannabis use disorder (CUD) impact stress-related hypothalamic-pituitary-adrenal (HPA) and immune function in this population. The research will...
This $2,419,326 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support a longitudinal study on neurobehavioral and psychosocial predictors of health risk behaviors from adolescence to young adulthood. The study aims to assess developmental trajectories of decision-making brain systems and their associations with substance use and other risky behaviors, as well as examine how psychosocial risk...
This $107,002 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support a cross-sectional, quantitative study exploring the impact of racism-related experiences (major discriminatory events, racial microaggressions, internalized racism, and historical trauma) on PTSD symptoms and polysubstance use among Black young adults. The study aims to measure these relationships and also psychometrically test the...
This federal Project Grant award of $157,684 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund a study to understand disparities in harm reduction services provided to persons with opioid use disorder in hospital settings. The key products and services to be delivered include: Developing and validating a natural language processing (NLP) system to identify patterns of harm reduction language and other relevant data from...
This $1,519,496 federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will fund a study to test the effectiveness of the PATH (Peer Advanced Training in Harm Reduction) workforce intervention. The intervention uses virtual education and case-based learning to support Peer Recovery Support Specialists (PRSS) who deliver harm reduction services. The goal is to reduce burnout among PRSS and (secondarily) improve service...
This federal Project Grant award for $903,965 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) supports research to determine whether the recruitment of an infralimbic (IL) prefrontal cortex driver circuit is a hallmark of heroin-induced pathology, whether this IL subcircuit engages a positive feedback loop via the orexin system to further exacerbate heroin seeking, and whether simultaneously targeting both IL subcircuits (driver and limiter) can...
This $4.68 million project grant from the National Institute on Drug Abuse, part of the Department of Health and Human Services, will fund research under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The University of Michigan will conduct a prospective cohort study of 400 adults with opioid-involved polysubstance use in Michigan. Researchers will collect detailed weekly data on participants' substance use patterns and motivations over four weeks to understand nuanced profiles...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under CFDA 93.279 - Drug Use and Addiction Research Programs is for a 2-year study titled "SILOS: Structural Inequities Across Layers of Social-Context as Drivers of HIV and Substance Use." The $2,332,704 award will fund innovative observational research across 5 U.S. cities to better understand how social contexts and inequities drive disparities in HIV and substance use among racial, ethnic, and sexual/gender...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,726,432 to study the co-use of cannabis and prescription opioids among emerging adults ages 18-25 in medical settings. The 5-year study, beginning in September 2024, will enroll emerging adults with and without a history of cannabis use who are prescribed opioids for acute pain management. The research aims to identify risk and...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $1,919,956.00 in funding to the University of Illinois to conduct a longitudinal study examining the social and environmental influences on substance use, mental health, and suicidality among non-prescriber/non-executive healthcare workers in the United States. The study will specifically focus on the effects of moral injury and workplace policies, programs, and practices on these outcomes over time. A sub-award of $52,720.35 was made to the Research Foundation for the State University of New York to support this research. The project aims to identify modifiable social and environmental risk factors that can inform more effective prevention and intervention efforts for this understudied population of healthcare workers, who have faced significant stress and trauma during the COVID-19 pandemic. The study will run from September 2024 through May 2029.